The
Innovation Pass will make selected innovative medicines available on the NHS
for a time-limited period, prior to a NICE appraisal. It gives earlier access
to innovative drugs for patients with the greatest need, and at the same time
will facilitate the collection of further information to support a subsequent
NICE appraisal. This consultation
seeks views from the NHS, industry and other stakeholders on the Government’s
proposals for an Innovation Pass pilot. These proposals will be revised
in light of comments received as part of this consultation and will be used to
inform the first set of decisions for the pilot in 2010/11. (Department
of Health - publications)
If you prefer to receive this content via email, you can sign up to our twice-weekly bulletin here: https://www.kingsfund.org.uk/emails
RSS feeds
All content
Changing configuration of health services
Commissioning
Competition and choice
Consultations
Developments in primary and community care
Equality and diversity
Integrated care
Leadership and leadership development
Local authorities, public health and health inequalities
Mental health
New technologies
NHS finances and productivity
NHS measurement and performance
Patient involvement, experience and feedback
Patient safety
Quality of care and clinical outcomes
Regulation, governance and accountability
Social care
Workforce and employment
Categories
- Brexit
- Commissioning
- Competition and choice
- Consultations
- Covid-19
- Digital health and data
- Environment and sustainability
- Equality and diversity
- General election
- Integrated care, collaboration and partnership
- Leadership and leadership development
- Legislation and reform
- Mental health
- NHS finance
- NHS performance and productivity
- Patient involvement, experience and feedback
- Patient safety
- Primary and community care
- Public health and health inequalities
- Quality of care and clinical outcomes
- Regulation, governance and accountability
- Social care
- Voluntary and community sector
- Workforce and employment